Development of an annual test to inform women about their future fertility

This contract involves the development of an annual diagnostic test designed to inform women about their future fertility by identifying new biomarkers that provide actionable insights for fertility planning. The test aims to assess a woman’s fertility status and predict the likely timeline for the onset of infertility, helping to guide decisions related to childbearing. The work is intended to generate data that will assist program managers in evaluating the feasibility of future initiatives focused on enhancing natural fertility before resorting to IVF treatments. Additionally, the project supports the advancement of women’s health monitoring tools by creating a test that is affordable, suitable for at least yearly use, and delivers straightforward results easily interpreted by patients and healthcare providers. The solicitation is issued by the Department of Health and Human Services through the ARPA-H agency, with a total small business set-aside designation, targeting companies with fewer than 500 employees under the SBIR/STTR mandate. The posted deadline for submission is July 10, 2026. This effort underscores a federal commitment to innovative women’s health solutions that enable proactive fertility management and aligns with the broader goal of improving reproductive health outcomes through accessible, user-friendly diagnostic technology.